Last updated on February 2019

Open-Label Extension and Safety Study of Talazoparib


Brief description of study

This is a single-arm, open-label, extended treatment, safety study in patients treated with talazoparib in qualifying studies.

Clinical Study Identifier: NCT02921919

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.